Asterias stem cell therapy shows promise in spinal cord paralysis: U.S. study

NEW YORK (Reuters) - An experimental stem cell therapy developed by Asterias Biotherapeutics restored some movement to patients paralyzed by recent spinal cord injuries, according to interim data from a small study being presented on Wednesday.